DPH3 and melanoma: Reporter assays carried out in one melanoma cell line for DPH3 and OXNAD1 orientations showed statistically significant, increased promoter activity due to −8/−9 CC > TT tandem mutations, although no effect was observed on DPH3 and OXNAD1 transcription in tumors [26].